[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2014 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 3.09%
YoY- 1.65%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 203,814 182,396 176,961 167,916 162,236 161,980 162,405 16.39%
PBT 41,210 48,792 46,509 43,452 42,604 44,700 40,175 1.71%
Tax -11,576 -12,916 0 -10,685 -10,820 -11,240 -7,900 29.09%
NP 29,634 35,876 46,509 32,766 31,784 33,460 32,275 -5.54%
-
NP to SH 29,634 35,876 35,271 32,766 31,784 33,460 32,275 -5.54%
-
Tax Rate 28.09% 26.47% 0.00% 24.59% 25.40% 25.15% 19.66% -
Total Cost 174,180 146,520 130,452 135,149 130,452 128,520 130,130 21.51%
-
Net Worth 190,284 205,045 192,942 187,436 179,045 190,050 181,850 3.07%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 11,193 - 25,679 7,404 11,103 - 24,293 -40.43%
Div Payout % 37.77% - 72.81% 22.60% 34.93% - 75.27% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 190,284 205,045 192,942 187,436 179,045 190,050 181,850 3.07%
NOSH 139,915 139,486 138,807 138,841 138,794 138,723 138,817 0.52%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 14.54% 19.67% 26.28% 19.51% 19.59% 20.66% 19.87% -
ROE 15.57% 17.50% 18.28% 17.48% 17.75% 17.61% 17.75% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 145.67 130.76 127.49 120.94 116.89 116.77 116.99 15.78%
EPS 21.18 25.72 25.41 23.60 22.90 24.12 23.25 -6.04%
DPS 8.00 0.00 18.50 5.33 8.00 0.00 17.50 -40.74%
NAPS 1.36 1.47 1.39 1.35 1.29 1.37 1.31 2.53%
Adjusted Per Share Value based on latest NOSH - 138,912
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 21.17 18.95 18.38 17.44 16.85 16.83 16.87 16.39%
EPS 3.08 3.73 3.66 3.40 3.30 3.48 3.35 -5.46%
DPS 1.16 0.00 2.67 0.77 1.15 0.00 2.52 -40.46%
NAPS 0.1977 0.213 0.2004 0.1947 0.186 0.1974 0.1889 3.09%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 2.65 3.88 2.50 3.17 2.97 3.03 2.58 -
P/RPS 1.82 2.97 1.96 2.62 2.54 2.59 2.21 -12.17%
P/EPS 12.51 15.09 9.84 13.43 12.97 12.56 11.10 8.32%
EY 7.99 6.63 10.16 7.44 7.71 7.96 9.01 -7.71%
DY 3.02 0.00 7.40 1.68 2.69 0.00 6.78 -41.76%
P/NAPS 1.95 2.64 1.80 2.35 2.30 2.21 1.97 -0.67%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 25/08/15 18/05/15 24/02/15 21/11/14 26/08/14 20/05/14 26/02/14 -
Price 2.40 3.90 2.92 3.01 3.37 3.09 2.60 -
P/RPS 1.65 2.98 2.29 2.49 2.88 2.65 2.22 -17.99%
P/EPS 11.33 15.16 11.49 12.75 14.72 12.81 11.18 0.89%
EY 8.83 6.59 8.70 7.84 6.80 7.81 8.94 -0.82%
DY 3.33 0.00 6.34 1.77 2.37 0.00 6.73 -37.52%
P/NAPS 1.76 2.65 2.10 2.23 2.61 2.26 1.98 -7.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment